Litcius/Paper detail

Integration of TADF Photosensitizer as “Electron Pump” and BSA as “Electron Reservoir” for Boosting Type I Photodynamic Therapy

Wenlong Chen, Zehui Wang, Mingyu Tian, Gaobo Hong, Yingnan Wu, Mengzhang Sui, Miaomiao Chen, Jing An, Fengling Song, Xiaojun Peng

2023Journal of the American Chemical Society229 citationsDOI

Abstract

Type I photosensitization provides an effective solution to the problem of unsatisfactory photodynamic therapeutic (PDT) effects caused by the tumor hypoxia. The challenge in the development of Type I mode is to boost the photosensitizer’s own electron transfer capacity. Herein, we found that the use of bovine serum albumin ( BSA ) to encapsulate a thermally activated delayed fluorescence (TADF) photosensitizer PS can significantly promote the Type I PDT process to generate a mass of superoxide anions (O 2 •– ). This Type I photosensitization opened a new strategy by employing BSA as “electron reservoir” and TADF photosensitizer as “electron pump”. We integrated these roles of BSA and PS in one system by preparing nanophotosensitizer PS@BSA . The Type I PDT performance was demonstrated with tumor cells under hypoxic conditions. Furthermore, PS@BSA took full advantage of the tumor-targeting role of BSA and achieved efficient PDT for tumor-bearing mice in the in vivo experiments. This work provides an effective route to improve the PDT efficiency of hypoxic tumors.

Topics & Concepts

PhotosensitizerChemistryPhotodynamic therapyBovine serum albuminElectron transferPhotochemistryIn vivoBiochemistryOrganic chemistryBiotechnologyBiologyNanoplatforms for cancer theranosticsPhotodynamic Therapy Research StudiesCancer, Hypoxia, and Metabolism